Health Care/Hospital

Frost & Sullivan Honors Komodo Health with Technology Innovation Leadership Award for Its Data-Driven Platform to Improve Patient Care

Komodo Health Delivers In-Depth and Actionable Patient-Level Insights for Enterprise Customers with its Robust Real-world Data, Advanced Analytics and AI-powered Algorithms, and Clinical and Industry Expertise SAN ANTONIO and SAN FRANCISCO, Nov. 2, 2023 /PRNewswire/ -- Frost & Sullivan  recently ...

2023-11-02 23:48 1033

Complete Genomics and Basepair™ Announce Technology Integration Partnership

SAN JOSE, Calif. and NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics' DNBSEQTM sequencing platforms*. The partnership gives ...

2023-11-02 21:00 675

Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore

SINGAPORE, Nov. 2, 2023 /PRNewswire/ -- At the annual Singapore Week of Innovation and Technology (SWITCH) 2023, Lion TCR, a clinical-stage mRNA-based T cell immunotherapy company, is thrilled to announce a significant milestoneof clinching the T-Up Excellence Awards. This award, in recognitio...

2023-11-02 20:41 1665

CPIC: Harvesting Success in Insurance Services for the Greater Bay Area, Successful Hosting of the 2023 Greater Bay Area Customer Festival Press Conference

HONG KONG, Nov. 2, 2023 /PRNewswire/ -- China Pacific Insurance (Group) Co., Ltd. ("CPIC" or the "Company", Stock Code: 02601) is pleased to announce that the 2023 CPIC Greater Bay Area Customer Festival Press Conference was held in Guangzhou on the afternoon of October 31 with great success, a...

2023-11-02 20:21 1596

Boryung Successfully Concludes 'Humans In Space Symposium' at 2023 ASCEND in Las Vegas

* HIS Symposium co-located with ASCEND, the world's event designed to accelerate the building of our sustainable off-world future, fromOctober 23 to 25. * Jay Kim, the Chairman and CEO of Boryung, invited as a speaker for ASCEND's opening and closing ceremonies and the panel discussion. * B...

2023-11-02 20:00 434

Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)

* FDA granted Breakthrough Therapy Designation for felzartamab in PMN upon positive clinical data from M-PLACE, a Phase 2 study led by I-Mab partner HI-Bio * I-Mab has full development and commercialization rights of felzartamab in Greater China for all indications, with Phase 3 multiple myelom...

2023-11-02 20:00 891

Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023

Potential First-in-Class Tetravalent Bispecific Antibody Demonstrates Enhanced Binding inthe Simultaneous Presence of PD-1 & VEGF Cooperative Binding of Ivonescimab Enables Higher Avidity in the Tumor Microenvironmentwith Over 18 Fold Increased Binding Affinity to PD-1 in the Presence of VEGF in...

2023-11-02 20:00 476

FWD Insurance unveils its new "Celebrate Easy. Celebrate Living" brand campaign

Launches two new regular premium investment-linked products, FWD WealthLink and FWD Wealthlink Pro  KUALA LUMPUR, Malaysia, Nov. 2, 2023 /PRNewswire/ -- FWD Insurance Berhad ("FWD Insurance") has unveiled its new brand campaign, "Celebrate Easy. Celebrate Living".  Inspired by the company's visi...

2023-11-02 18:54 1072

European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for patients with BRAFV600-mutant advanced non-small cell lung cancer (NSCLC)

- BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) shows meaningful clinical benefit in adult patients with BRAFV600-mutant advanced NSCLC - The application is based on results from the PHAROS study,[1] which showed an objective response rate of 75% in treatment-naïve patients and 46% in previou...

2023-11-02 18:52 663

Cambrex Announces Sale of Drug Product Business Unit

EAST RUTHERFORD, N.J., Nov. 2, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), has today completed the sale of its Drug Product Business Unit toWilmington, Delaware based Noramco. Cambrex's Drug Product business provides product developme...

2023-11-02 18:00 1102

Chipscreen's New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis

SHENZHEN, China, Nov. 2, 2023 /PRNewswire/ -- On Oct. 31, 2023, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen" and with stock code 688321.SH) received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration ("NMPA") thro...

2023-11-02 15:58 1092

Xinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi

BEIJING, Nov. 2, 2023 /PRNewswire/ -- The 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair was held recently in Zhangshu, a county-level city in eastChina's Jiangxi Province. Photo shows the opening ceremony of the 54th Zh...

2023-11-02 14:21 1613

Myrkl - The NEW Liver Function and Detox Support Supplement that sold out in 24hrs

Enjoy socialising without sacrificing the next day! AUCKLAND, New Zealand, Nov. 2, 2023 /PRNewswire/ -- Myrkl (pronounced myr-a-kle)is the new liver function and detox support supplement that is taking the world by storm. This innovative supplement contains patented AB001™ which activates i...

2023-11-02 11:25 1388

Fonterra shares New Zealand's best farming practices to upskill Thai dairy farmers

PAK CHONG, Thailand, Nov. 2, 2023 /PRNewswire/ -- New Zealand's largest dairy co-operative, Fonterra joined hands today with the Thai government to help upskill Thai dairy farmers and improve local farming practices. The 3-day dairy development program currently underway at the Nakornratchashima...

2023-11-02 11:22 1428

Chula Launches the Latest Parkinson's Gloves to Reduce Tremors

BANGKOK, Nov. 2, 2023 /PRNewswire/ -- Chula   medical researchershave developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication an...

2023-11-02 10:00 1496

Precision, Effectiveness, and Intelligence: Explore the Latest Trend of Healthcare and Medical Equipment Industry at 134th Canton Fair

GUANGZHOU, China, Nov. 1, 2023 /PRNewswire/ -- As the public is paying increasing attention to health management, the 5-day onsite exhibition of Phase 3 of the 134th Canton Fair held from October 31st to November 4th will present nearly 600 quality exhibitors in medical and healthcare industries ...

2023-11-02 08:00 1549

TraceLink MINT Wins 2023 Pharma Innovation Award: 100% End-to-End Supply Chain Digitalization is Now Within Reach

100% End-to-End Supply Chain Digitalization is Now Possible with Proven Network Orchestration Capability BOSTON, Nov. 2, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life...

2023-11-02 05:22 1516

Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine

PALO ALTO, Calif., Nov. 1, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com ), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto, CA, and Heartseed Inc. ("Heartseed"), a Tokyo-based bio...

2023-11-02 00:00 1433

Treasure Global's ZCITY App Signs a Memorandum of Understanding with Malaysia's Leading Healthcare Group, UCSI Hospital, to Pioneer Stem Cell Healthcare Tourism for Indonesia, Hong Kong and Mainland China

- Through this partnership, TGL will further monetize its user base and expects a projected 100%monthly gross profit increase from this partnership - NEW YORK and KUALA LUMPUR, Malaysia, Nov. 1, 2023 /PRNewswire/ -- Treasure Global Inc (NASDAQ: TGL) ("TGL," "Treasure Global" or the "Company"), an...

2023-11-01 22:53 1429

Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction

The Group is Advancing the Program to a Phase II Clinical Study Data presented at the 2023 Fall Clinical Dermatology Conference HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Nov. 1, 2023 /PRNewswire/ --Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries,...

2023-11-01 22:07 1765
1 ... 77787980818283 ... 808